Alzheimer disease: advances in imaging of AD biomarkers could aid early diagnosis
- PMID: 24752129
- DOI: 10.1038/nrneurol.2014.71
Alzheimer disease: advances in imaging of AD biomarkers could aid early diagnosis
Similar articles
-
Development of Alzheimer-disease neuroimaging-biomarkers using mouse models with amyloid-precursor protein-transgene expression.Prog Neurobiol. 2011 Dec;95(4):547-56. doi: 10.1016/j.pneurobio.2011.05.004. Epub 2011 May 12. Prog Neurobiol. 2011. PMID: 21601614 Review.
-
Biomarkers do not paint the whole picture: The role of clinical expertise and advanced neuroimaging for Alzheimer's disease diagnosis.J Alzheimers Dis. 2025 May;105(2):370-374. doi: 10.1177/13872877251328953. Epub 2025 Mar 20. J Alzheimers Dis. 2025. PMID: 40111924
-
The Legal Implications of Detecting Alzheimer's Disease Earlier.AMA J Ethics. 2016 Dec 1;18(12):1207-1217. doi: 10.1001/journalofethics.2016.18.12.hlaw1-1612. AMA J Ethics. 2016. PMID: 28009247
-
Prospective interest of molecular neuroimaging in Alzheimer's disease.Rev Neurol (Paris). 2013 Jan;169(1):9-13. doi: 10.1016/j.neurol.2012.03.007. Epub 2012 Jun 6. Rev Neurol (Paris). 2013. PMID: 22682055 Review.
-
Isn't amyloid more than just a marker for Alzheimer disease?Neurology. 2009 Oct 13;73(15):1174-5. doi: 10.1212/WNL.0b013e3181be020a. Epub 2009 Sep 9. Neurology. 2009. PMID: 19741212 No abstract available.
Cited by
-
Use of curcumin in diagnosis, prevention, and treatment of Alzheimer's disease.Neural Regen Res. 2018 Apr;13(4):742-752. doi: 10.4103/1673-5374.230303. Neural Regen Res. 2018. PMID: 29722330 Free PMC article. Review.
-
Association between LRP1 C766T polymorphism and Alzheimer's disease susceptibility: a meta-analysis.Sci Rep. 2017 Aug 16;7(1):8435. doi: 10.1038/s41598-017-08335-w. Sci Rep. 2017. PMID: 28814781 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical